4.6 Review

Human Parvoviruses

Journal

CLINICAL MICROBIOLOGY REVIEWS
Volume 30, Issue 1, Pages 43-113

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/CMR.00040-16

Keywords

B19 virus; human bocavirus; parvovirus

Categories

Funding

  1. National Institute of Allergy and Infectious Diseases [AI105543, AI112803]
  2. Centers of Biomedical Research Excellence (COBRE) Program of the National Institute of General Medical Sciences, National Institutes of Health [P30 GM103326]
  3. Finnish Medical Foundation
  4. Sigrid Juselius Foundation
  5. Medical Association Liv och Halsa
  6. Helsinki University
  7. Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health

Ask authors/readers for more resources

Parvovirus B19 (B19V) and human bocavirus 1 (HBoV1), members of the large Parvoviridae family, are human pathogens responsible for a variety of diseases. For B19V in particular, host features determine disease manifestations. These viruses are prevalent worldwide and are culturable in vitro, and serological and molecular assays are available but require careful interpretation of results. Additional human parvoviruses, including HBoV2 to -4, human parvovirus 4 (PARV4), and human bufavirus (BuV) are also reviewed. The full spectrum of parvovirus disease in humans has yet to be established. Candidate recombinant B19V vaccines have been developed but may not be commercially feasible. We review relevant features of the molecular and cellular biology of these viruses, and the human immune response that they elicit, which have allowed a deep understanding of pathophysiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available